210 related articles for article (PubMed ID: 22953503)
1. Theory and practical application of superficial atypical melanocytic proliferations of uncertain significance (SAMPUS) and melanocytic tumours of uncertain malignant potential (MELTUMP) terminology: experience with second opinion consultation.
Pusiol T; Morichetti D; Piscioli F; Zorzi MG
Pathologica; 2012 Apr; 104(2):70-7. PubMed ID: 22953503
[TBL] [Abstract][Full Text] [Related]
2. Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the Netherlands.
Vermariën-Wang J; Doeleman T; van Doorn R; Mooyaart AL; Blokx WAM; Schrader AMR
J Am Acad Dermatol; 2023 Mar; 88(3):602-608. PubMed ID: 36403750
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features, Dermoscopic Patterns, and Histological Diagnostic Model for Melanocytic Tumors of Uncertain Malignant Potential (MELTUMP).
Pusiol T; Piscioli F; Speziali L; Zorzi MG; Morichetti D; Roncati L
Acta Dermatovenerol Croat; 2015; 23(3):185-94. PubMed ID: 26476902
[TBL] [Abstract][Full Text] [Related]
4. SAMPUS, MELTUMP and THIMUMP - Diagnostic Categories Characterized by Uncertain Biological Behavior.
Roncati L; Piscioli F; Pusiol T
Klin Onkol; 2017; 30(3):221-223. PubMed ID: 28612620
[TBL] [Abstract][Full Text] [Related]
5. The approach to the patient with a difficult melanocytic lesion.
Elder DE; Xu X
Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112
[TBL] [Abstract][Full Text] [Related]
6. Highlighting the immunohistochemical profile of melanocytomas: review.
Quatresooz P; Piérard-Franchimont C; Piérard GE
Oncol Rep; 2008 Jun; 19(6):1367-72. PubMed ID: 18497938
[TBL] [Abstract][Full Text] [Related]
7. Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions.
van Dijk MC; Aben KK; van Hees F; Klaasen A; Blokx WA; Kiemeney LA; Ruiter DJ
Histopathology; 2008 Jan; 52(2):139-46. PubMed ID: 18184263
[TBL] [Abstract][Full Text] [Related]
8. Performance of PRAME immunohistochemistry compared with that of c-Kit, c-Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors.
Jung JM; Lee MY; Won CH; Chang SE; Lee MW; Lee WJ
Pathol Int; 2023 Jan; 73(1):27-36. PubMed ID: 36468840
[TBL] [Abstract][Full Text] [Related]
9. [Melanocytic tumour of uncertain malignant potential; practical dilemmas].
Rozendaal AM; de Haas ERM; Mooi W; de Roos KP
Ned Tijdschr Geneeskd; 2019 Jul; 163():. PubMed ID: 31283126
[TBL] [Abstract][Full Text] [Related]
10. Epiluminescence microscopy features of cutaneous malignant melanoma metastases.
Schulz H
Melanoma Res; 2000 Jun; 10(3):273-80. PubMed ID: 10890382
[TBL] [Abstract][Full Text] [Related]
11. [Intraepidermal melanocytic proliferation. A practical guide to the classification of ambiguous melanotic skin lesions and of possible precursors of malignant melanomas].
Prade M; Levene A; Bailly C; Cesarini JP; Van der Esch E; Smith N; Suurkula M; Verhest A
Bull Cancer; 1986; 73(5):504-12. PubMed ID: 3779132
[TBL] [Abstract][Full Text] [Related]
12. Minimal deviation melanoma. Borderline and intermediate melanocytic neoplasia.
Reed RJ
Clin Lab Med; 2000 Dec; 20(4):745-58. PubMed ID: 11221513
[TBL] [Abstract][Full Text] [Related]
13. [Thermographic examination of cutaneous melanocytic nevi].
Mikulska D
Ann Acad Med Stetin; 2009; 55(1):31-8; discussion 38. PubMed ID: 20349589
[TBL] [Abstract][Full Text] [Related]
14. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").
Barnhill RL; Argenyi Z; Berwick M; Duray PH; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Paine S; Piepkorn MW; Prieto V; Rabkin MS; Schmidt B; Selim A; Shea CR; Trotter MJ
Am J Surg Pathol; 2008 Jan; 32(1):36-44. PubMed ID: 18162768
[TBL] [Abstract][Full Text] [Related]
15. Melanocytic lesions of the genital area with attention given to atypical genital nevi.
Ribé A
J Cutan Pathol; 2008 Nov; 35 Suppl 2():24-7. PubMed ID: 18976416
[TBL] [Abstract][Full Text] [Related]
16. Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party.
Veenhuizen KC; De Wit PE; Mooi WJ; Scheffer E; Verbeek AL; Ruiter DJ
J Pathol; 1997 Jul; 182(3):266-72. PubMed ID: 9349228
[TBL] [Abstract][Full Text] [Related]
17. Borderline and atypical melanocytic lesions.
Brodell RT; Santa Cruz DJ
Semin Diagn Pathol; 1985 Feb; 2(1):63-86. PubMed ID: 3916688
[TBL] [Abstract][Full Text] [Related]
18. Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma.
Scolyer RA; Zhuang L; Palmer AA; Thompson JF; McCarthy SW
Pathology; 2004 Oct; 36(5):419-27. PubMed ID: 15370111
[TBL] [Abstract][Full Text] [Related]
19. Histogenetic categorization of atypical melanocytic tumor of uncertain biological malignant potential.
Pusiol T
An Bras Dermatol; 2018; 93(4):608-609. PubMed ID: 30066780
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]